Kingsview Wealth Management LLC Invests $10.29 Million in Cigna Group $CI

Kingsview Wealth Management LLC bought a new stake in Cigna Group (NYSE:CI) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 37,331 shares of the health services provider’s stock, valued at approximately $10,291,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. GQG Partners LLC purchased a new position in Cigna Group during the second quarter worth about $1,628,918,000. Norges Bank purchased a new stake in Cigna Group in the 4th quarter valued at approximately $1,019,790,000. Northwestern Mutual Wealth Management Co. boosted its holdings in Cigna Group by 13,333.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after purchasing an additional 3,141,844 shares in the last quarter. Bank of America Corp DE acquired a new position in Cigna Group during the 2nd quarter worth approximately $827,692,000. Finally, Legal & General Group Plc acquired a new position in Cigna Group during the 2nd quarter worth approximately $542,779,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Stock Performance

CI opened at $278.89 on Friday. The stock has a market cap of $73.69 billion, a P/E ratio of 11.54, a P/E/G ratio of 0.96 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The stock’s 50 day simple moving average is $283.52 and its 200 day simple moving average is $281.39. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.Cigna Group’s revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Insider Buying and Selling at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 23,012 shares of company stock valued at $6,386,550 in the last ninety days. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Robert W. Baird set a $362.00 price target on Cigna Group in a report on Friday, July 31st. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $303.00 to $302.00 in a report on Wednesday, May 20th. Raymond James Financial cut Cigna Group from a “strong-buy” rating to an “outperform” rating and cut their price objective for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Sanford C. Bernstein raised their target price on Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a report on Thursday, July 9th. Finally, Mizuho boosted their target price on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.